Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,694.00",
    "chg": -8.3,
    "chgp": "-0.49%",
    "dir": -1,
    "prev_price": "1,702.30",
    "mcapval": "405,728.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "12.93 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Gains 6.25%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-gains-625-4-key-factors-driving-the-weeks-momentum-3826203",
        "imagepath": "",
        "date": "2026-02-07 14:03:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Technical momentum shifts to sideways trend with mixed signals</p>\n                    <p><strong>3 Feb:</strong> Intraday high of Rs.1,725 reached amid strong 3.42% surge</p>\n                    <p><strong>3 Feb:</strong> Significant 5.41% gap up opening marks renewed buying interest</p>\n                    <p><strong>3 Feb:</strong> Surge in call option activity at Rs.1,700 strike signals bullish positioning</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.1,694.70, up 6.25% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cla..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-amid-mixed-market-signals-3823824",
        "imagepath": "",
        "date": "2026-02-06 09:21:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable prestige and liquidity advantages to Sun Pharmaceutical Industries Ltd. The index, representing the top 50 companies by free-float market capitalisation on the National Stock Exchange, serves as a barometer for the Indian equity market. Inclusion ensures enhanced visibility among domestic and global investors, often translating into sustained demand from index funds and institutional investors tracking the benchmark.</p>\n                <p>Sun Pharma’s market capitalisation stands at a robust ₹4,08,439 crores, firmly placing it among the large-cap elite. This stature not only underpins its index membership but also influences the weighting it carries within..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership Amid Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-amid-mixed-performance-3821947",
        "imagepath": "",
        "date": "2026-02-05 09:21:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries Ltd at the forefront of India’s equity market landscape. This membership not only reflects the company’s sizeable market capitalisation—currently standing at ₹4,04,587.86 crores—but also its liquidity and investor appeal. Index inclusion ensures that the stock is a core holding for numerous mutual funds, exchange-traded funds (ETFs), and institutional portfolios that track or benchmark against the Nifty 50.</p>\n                <p>This status often results in enhanced trading volumes and greater analyst coverage, which can contribute to more efficient price discovery. However, it also subjects the stock to index rebalancing risks and the broa..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership and Institutional Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-3820031",
        "imagepath": "",
        "date": "2026-02-04 09:21:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable prestige and influence on Sun Pharmaceutical Industries Ltd. As one of the 50 largest and most liquid stocks on the National Stock Exchange of India, its inclusion ensures substantial institutional interest and passive fund inflows. Index funds and ETFs tracking the Nifty 50 are mandated to hold shares of Sun Pharma, which supports liquidity and price stability. This membership also places the company under the constant scrutiny of analysts and investors, making its performance a bellwether for the Pharmaceuticals & Biotechnology sector.</p>\n                <p>Sun Pharma’s market capitalisation stands at a robust ₹4,11,138.04 crores, firmly categorising it ..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3818139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_gapup_3818139.png",
        "date": "2026-02-03 10:03:40",
        "description": "Sun Pharmaceutical Industries Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 5.41% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by sustained momentum throughout the day, with the stock outperforming both its sector and the broader market indices."
      },
      {
        "title": "Sun Pharmaceutical Sees Surge in Call Option Activity Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-amid-bullish-momentum-3818084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_most_active_stocks_calls_3818084.png",
        "date": "2026-02-03 10:01:14",
        "description": "Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in call option trading, signalling increased bullish sentiment among investors. The pharmaceutical giant’s stock has outperformed its sector peers, supported by strong price action and significant open interest in near-term call options, particularly at the ₹1700 strike price expiring on 24 February 2026."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Hits Intraday High with Strong 3.42% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-intraday-high-with-strong-342-surge-3817758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_priceRelatedfactors_3817758.png",
        "date": "2026-02-03 09:44:37",
        "description": "Sun Pharmaceutical Industries Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 1,725, marking a 5.9% rise from the previous close. The stock outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting strong trading momentum amid a mixed market backdrop."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-market-dynamics-3817454",
        "imagepath": "",
        "date": "2026-02-03 09:24:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index is a hallmark of market leadership and liquidity. Sun Pharmaceutical Industries Ltd’s inclusion reflects its substantial market capitalisation, robust trading volumes, and sectoral prominence. With a market cap of ₹4,04,179.97 crores, it ranks among the largest pharmaceutical companies in India, reinforcing its role as a bellwether for the sector.</p>\n                <p>Index membership not only enhances visibility among domestic and global investors but also ensures automatic inclusion in numerous passive funds and ETFs tracking the Nifty 50. This institutional interest often translates into greater stability and liquidity, although it can also amplify volatility during index ..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3815518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaceutic_technicaldot_3815518.png",
        "date": "2026-02-02 08:04:50",
        "description": "Sun Pharmaceutical Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.95%, the stock’s broader technical signals suggest a cautious outlook amid mixed momentum cues."
      }
    ],
    "total": 973,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Feb-2026",
      "details": "Newspaper Advertisement for special window for transfer of Physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "04-Feb-2026",
      "details": "Q3FY26 Earnings Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Feb-2026",
      "details": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Gains 6.25%: 4 Key Factors Driving the Week’s Momentum

2026-02-07 14:03:04

Key Events This Week

2 Feb: Technical momentum shifts to sideways trend with mixed signals

3 Feb: Intraday high of Rs.1,725 reached amid strong 3.42% surge

3 Feb: Significant 5.41% gap up opening marks renewed buying interest

3 Feb: Surge in call option activity at Rs.1,700 strike signals bullish positioning

6 Feb: Week closes at Rs.1,694.70, up 6.25% for the week

Week Open

Read full news article

Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership Amid Mixed Market Signals

2026-02-06 09:21:05

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable prestige and liquidity advantages to Sun Pharmaceutical Industries Ltd. The index, representing the top 50 companies by free-float market capitalisation on the National Stock Exchange, serves as a barometer for the Indian equity market. Inclusion ensures enhanced visibility among domestic and global investors, often translating into sustained demand from index funds and institutional investors tracking the benchmark.

Sun Pharma’s market capitalisation stands at a robust ₹4,08,439 crores, firmly placing it among the large-cap elite. This stature not only underpins its index membership but also influences the weighting it carries within...

Read full news article

Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership Amid Mixed Performance

2026-02-05 09:21:16

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries Ltd at the forefront of India’s equity market landscape. This membership not only reflects the company’s sizeable market capitalisation—currently standing at ₹4,04,587.86 crores—but also its liquidity and investor appeal. Index inclusion ensures that the stock is a core holding for numerous mutual funds, exchange-traded funds (ETFs), and institutional portfolios that track or benchmark against the Nifty 50.

This status often results in enhanced trading volumes and greater analyst coverage, which can contribute to more efficient price discovery. However, it also subjects the stock to index rebalancing risks and the broa...

Read full news article

Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership and Institutional Dynamics

2026-02-04 09:21:02

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable prestige and influence on Sun Pharmaceutical Industries Ltd. As one of the 50 largest and most liquid stocks on the National Stock Exchange of India, its inclusion ensures substantial institutional interest and passive fund inflows. Index funds and ETFs tracking the Nifty 50 are mandated to hold shares of Sun Pharma, which supports liquidity and price stability. This membership also places the company under the constant scrutiny of analysts and investors, making its performance a bellwether for the Pharmaceuticals & Biotechnology sector.

Sun Pharma’s market capitalisation stands at a robust ₹4,11,138.04 crores, firmly categorising it ...

Read full news article

Sun Pharmaceutical Industries Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 10:03:40

Sun Pharmaceutical Industries Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 5.41% higher than its previous close, signalling robust positive sentiment in the Pharmaceuticals & Biotechnology sector. This strong start was accompanied by sustained momentum throughout the day, with the stock outperforming both its sector and the broader market indices.

Read full news article

Sun Pharmaceutical Sees Surge in Call Option Activity Amid Bullish Momentum

2026-02-03 10:01:14

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in call option trading, signalling increased bullish sentiment among investors. The pharmaceutical giant’s stock has outperformed its sector peers, supported by strong price action and significant open interest in near-term call options, particularly at the ₹1700 strike price expiring on 24 February 2026.

Read full news article

Sun Pharmaceutical Industries Ltd Hits Intraday High with Strong 3.42% Surge

2026-02-03 09:44:37

Sun Pharmaceutical Industries Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 1,725, marking a 5.9% rise from the previous close. The stock outpaced the broader Pharmaceuticals & Biotechnology sector and the Sensex, reflecting strong trading momentum amid a mixed market backdrop.

Read full news article

Sun Pharmaceutical Industries Ltd: Navigating Nifty 50 Membership and Market Dynamics

2026-02-03 09:24:12

Significance of Nifty 50 Membership

Being part of the Nifty 50 index is a hallmark of market leadership and liquidity. Sun Pharmaceutical Industries Ltd’s inclusion reflects its substantial market capitalisation, robust trading volumes, and sectoral prominence. With a market cap of ₹4,04,179.97 crores, it ranks among the largest pharmaceutical companies in India, reinforcing its role as a bellwether for the sector.

Index membership not only enhances visibility among domestic and global investors but also ensures automatic inclusion in numerous passive funds and ETFs tracking the Nifty 50. This institutional interest often translates into greater stability and liquidity, although it can also amplify volatility during index ...

Read full news article

Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-02 08:04:50

Sun Pharmaceutical Industries Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.95%, the stock’s broader technical signals suggest a cautious outlook amid mixed momentum cues.

Read full news article

View All News